Jane Hughes
BA Hons, MPH
School of Health and Related Research
Study Manager
jane.hughes2@sheffield.ac.uk
+44 114 222 0762
+44 114 222 0762
2.11, CTRU, The Innovation Centre
Full contact details
Jane Hughes
School of Health and Related Research
2.11, CTRU
The Innovation Centre
217 Portobello
Sheffield
S1 4DP
School of Health and Related Research
2.11, CTRU
The Innovation Centre
217 Portobello
Sheffield
S1 4DP
- Profile
-
I am a study manager on an NIHR RCT - STOP-OHSS – a multi-centre trial evaluating an intervention for women who develop ovarian hyperstimulation as a result of fertility treatment.
Previously within ScHARR I was a research associate working on;
- Scottish Minimum Unit Pricing for Alcohol study (SARG) – an evaluation of the MUP for alcohol policy in Scotland.
- TIME study – A take-home naloxone intervention multicentre emergency setting feasibility trial.
- NIHR funded - The Design, Development, Commissioning and Evaluation of Patient Focused Vascular Services study - (HEDS).
- Cancer, Fertility and Me study - developing and evaluating a decision aid for women diagnosed with cancer considering fertility preservation (HEDS).
Before joining ScHARR I was a Clinical Data Manager at the Sheffield University Cancer Clinical Trials Unit – working on a variety of cancer drug clinical trials. I gained an MPH at ScHARR in 2012.
- Research interests
-
Recruitment to clinical trials/research trials.
- Publications
-
Show: Featured publications All publications
Featured publications
This person does not have any publications available.
All publications
Journal articles
- It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders. Qualitative Research in Medicine and Healthcare, 4(3), 117-131. View this article in WRRO
- Protocol for Take-home naloxone In Multicentre Emergency (TIME) settings: feasibility study. Pilot and Feasibility Studies, 6(1). View this article in WRRO
- Electronic personal assessment questionnaire for vascular patients (ePAQ-VAS) development and validity. British Journal of Surgery. View this article in WRRO
- Strength of public preferences for endovascular or open aortic aneurysm repair. British Journal of Surgery, 106(13), 1775-1783. View this article in WRRO
- Are publicly available internet resources enabling women to make informed fertility preservation decisions before starting cancer treatment: An environmental scan? 11 Medical and Health Sciences 1117 Public Health and Health Services. BMC Medical Informatics and Decision Making, 18(1). View this article in WRRO
- Preserving fertility in women with cancer (PreFer): Decision‐making and patient‐reported outcomes in women offered egg and embryo freezing prior to cancer treatment. Psycho-Oncology.
- What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?. Human Reproduction Update, 23(4), 433-457.
- Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol. BMJ Open, 7(3). View this article in WRRO
- The impact of surgery for vulval cancer upon health-related quality of life and pelvic floor outcomes during the first year of treatment: a longitudinal, mixed methods study. Psycho-Oncology, 25(6), 656-662. View this article in WRRO
- 141. Factors influencing risk management choices (risk reducing surgery or screening) in women at high familial breast cancer risk. European Journal of Surgical Oncology, 38(9), 778-779.
- Psychosocial and physical outcomes for women at high familial breast cancer risk. European Journal of Surgical Oncology (EJSO), 36(11), 1107-1107.
Conference proceedings papers
- Experiences of women and partners of women at increased familial breast cancer risk: A qualitative study of the impact upon partnerships. European Journal of Surgical Oncology, Vol. 44(6) (pp 904-905)
- Views and experiences of MRI breast screening in women at increased familial breast cancer risk. European Journal of Surgical Oncology, Vol. 44(6) (pp 905-906), 18 June 2018 - 19 June 2018. View this article in WRRO
Other
- Author response to: Comment on: Strength of public preferences for endovascular or open aortic aneurysm repair. British Journal of Surgery, 107(5), 613-614.
- It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders. Qualitative Research in Medicine and Healthcare, 4(3), 117-131. View this article in WRRO